U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 330 records

Showing results for "sedation".

  1. Cannabis-2022-Surv-Rep-4-Table-F5 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
    January 01, 2022 - C Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

  2. Cannabis-2023-Surv-Rep-4-Table-E-5 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
    January 01, 2023 - C Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

  3. Amended Protocol: Interventions for Breathlessness in Patients with Advanced Cancer (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
    May 19, 2020 - rate • Blood pressure • Objective measure of exercise capacity, e.g., 6-minute walk test • Level of sedation … bicarbonate levels • Heart rate • Blood pressure • Objective measure of exercise capacity • Level of sedation

  4. Comparative Effectiveness of Strategies to De-escalate Aggressive Behavior in Psychiatric Patients in Acute Care Settings (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
    October 01, 2016 - psychiatrically ill, violently agitated patients requiring chemical restraint produced more rapid sedation … and greater sedation overall than intramuscular lorazepam68 (one RCT, insufficient SOE). … other medication protocols: Benefits (continued) Change in aggressive behavior (continued) Sedation … Another RCT reported on acute extrapyramidal events and incidence of marked sedation in a comparison … flunitrazepam at 90 minutes.48 Marked sedation 28 Insufficient Medium risk of bias, consistency

  5. Crosscutting-Horizon-Scan-High-Impact-1506 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - Computer-assisted system (Sedasys) for propofol sedation during gastrointestinal endoscopy procedures …  Computer-assisted system (Sedasys) for propofol sedation during gastrointestinal endoscopy procedures … system intended to aid clinicians in delivering propofol for minimal to moderate sedation during routine … The Sedasys sedation system is intended to allow teams led by physicians who are not anesthesiologists … expressed views that the Sedasys system does not address a significant unmet need because alternative sedation

  6. Identification and Treatment of Post-Acute Coronary Syndrome (ACS) Depression: A Systematic Review | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/acs-depression/research-protocol
    August 31, 2016 - Other risks: akathisia, restlessness, sedation, headache, nausea and vomiting Olanzapine 6 For … safety alert: DRESS (drug reaction with eosinophilia and systemic symptoms) FDA black box: delirium/sedation … syndrome with long acting injection (likely not relevant to use in depression) Other risks: akathisia, sedation … Quetiapine 7 Yes, as an adjunct with an antidepressant Other risks: sedation, hypertension, cataracts … but not limited to constipation, urinary retention and blurred vision) and CNS depression including sedation

  7. Identification and Treatment of Post-Acute Coronary Syndrome (ACS) Depression: A Systematic Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
    February 15, 2017 - Other risks: akathisia, restlessness, sedation, headache, nausea and vomiting Olanzapine6 For bipolar … safety alert: DRESS (drug reaction with eosinophilia and systemic symptoms) FDA black box: delirium/sedation … syndrome with long acting injection (likely not relevant to use in depression) Other risks: akathisia, sedation … Quetiapine7 Yes, as an adjunct with an antidepressant Other risks: sedation, hypertension, cataracts … but not limited to constipation, urinary retention and blurred vision) and CNS depression including sedation

  8. Evidence Report on the (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
    December 01, 2010 - terms of extrapyramidal side effects and tardive dyskinesia, but produce other side effects, including sedation … General: extrapyramidal side effects, weight gain, agitation, constipation, sedation, elevated cholesterol … behaviors, death by suicide  General: extrapyramidal effects, weight gain, agitation, constipation, sedation … • General adverse events: extrapyramidal effects, weight gain, agitation, constipation, sedation,

  9. Pharmacologic and Nonpharmacologic Treatments of Posttraumatic Stress Disorder (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-repository-expanded-protocol.pdf
    October 24, 2019 - Pharmacologic and Nonpharmacologic Treatments of Posttraumatic Stress Disorder Evidence-based Practice Center Systematic Review Protocol Project Title: Pharmacologic and Nonpharmacologic Treatments of Posttraumatic Stress Disorder I. Background and Objectives for the Systematic Review Posttraumatic stress…

  10. Pharmacologic and Nonpharmacologic Treatments of Posttraumatic Stress Disorder (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-repository-expanded-protocol.pdf
    October 24, 2019 - Pharmacologic and Nonpharmacologic Treatments of Posttraumatic Stress Disorder Evidence-based Practice Center Systematic Review Protocol Project Title: Pharmacologic and Nonpharmacologic Treatments of Posttraumatic Stress Disorder I. Background and Objectives for the Systematic Review Posttraumatic stress…

  11. Draft-Living-Review-Plant-Chronic-Pain-E-Evidence-Tables (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/draft-living-review-plant-chronic-pain-e-evidence-tables.xlsx
    March 25, 2024 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis

  12. Plant-Based-Chronic-Pain-Appendix-F1-F4-Jan-2020 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-chronic-pain-appendix-f1-f4-jan-2020.xlsx
    January 01, 2020 - Events Serious Adverse Events Withdrawal Due to Adverse Events Dizziness Nausea Sedation … Intervention B, N Analyzed for nausea (denominator) Intervention B, % with nausea Intervention A, N of sedation … (numerator) Intervention A, N Analyzed for sedation (denominator) Intervention A, % with sedation Intervention … B, N of sedation (numerator) Intervention B, N Analyzed for sedation (denominator) Intervention B, … % with sedation Intervention A, N of Cannabis Use Disorder (numerator) Intervention A, N Analyzed for

  13. Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/atypical-antipsychotics-off-label-update/research-protocol
    May 19, 2010 - that atypical antipsychotics can increase chances of adverse events such as significant weight gain, sedation … Neurological Cerebrovascular accident (CVA) Akathisia Extrapyramidal Symptoms Tardive Dyskinesia Sedation

  14. Evidence Report on the (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
    May 19, 2010 - that atypical antipsychotics can increase chances of adverse events such as significant weight gain, sedation … Source: www.effectivehealthcare.ahrq.gov Published Online: May 19, 2010 Tardive Dyskinesia Sedation

  15. Autism-Adolescents Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-adolescents_executive.pdf
    August 01, 2012 - Harms or adverse effects reported in studies of antipsychotic medications included sedation, gastrointestinal … depression.21,40,44 Adverse effects described in the study of naltrexone included nausea, fatigue, sedation … in studies of SRIs included fatigue, tremor, tachycardia, agitation, gastrointestinal complaints, sedation … As in the case of efficacy, the data on adverse effects associated with risperidone, including sedation

  16. Appendixes A-I (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-appendices.pdf
    January 16, 2023 - or disability, including pain interferencea); harms and adverse effects (e.g., dizziness, nausea, sedation … Sensitivity analysis of sedation for high-THC versus placebo (short term, 1 to 6 months followup) … Placebo Sedation 6 RCTs (N=866)1,2,4-7 Moderate Direct Consistent Imprecise Unknown Large effect … Placebo Sedation 4 RCTs (N=335)9- 12 Moderate Direct Consistent Imprecise Unknown Moderate effect … Gabapentin Alone) Sedation 1 cohort study, short- and intermediate-term (N=156)21 Moderate

  17. Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/clinician
    August 31, 2016 - fairly immediate in nature: Adverse events frequently reported with risperidone included weight gain, sedation

  18. Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_clinician.pdf
    August 01, 2016 - immediate in nature: �– Adverse events frequently reported with risperidone included weight gain, sedation

  19. Draft-Living-Review-Plant-Chronic-Pain-E-Cohort-Studies (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/draft-living-review-plant-chronic-pain-e-cohort-studies.xlsx
    March 25, 2024 - C Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

  20. Comparative Effectiveness of Treatments for Cryptorchidism | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/undescended-testicle/research-protocol
    September 02, 2011 - Imaging approaches include magnetic resonance angiography, which requires sedation or anesthesia and … Need for further surgical intervention Adverse effects, including but not limited to effects of sedation
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites